Actym Therapeutics has announced that an abstract highlighting detailed preclinical data of its lead candidate, ACTM-838, was accepted for presentation at the Society for Immunotherapy of Cancer 37th Annual Meeting.

Agilent Technologies Inc. has become a member of How2Recycle®, a standardized labeling system owned by Delaware nonprofit Green Blue Institute, Inc.

OncoHost has developed a novel predictive model for clinical benefit of immune checkpoint inhibitor in non-small cell lung cancer patients.

Arima Genomics, Inc. has announced a new partnership with Basepair to empower scientists with new options for bioinformatic analysis of 3D genomic data.

Particle Works continues to pave the way for particle perfection with the highly anticipated launch of its second revolutionary platform, the Automated Library Synthesis (ALiS) System.

Lonza has launched an innovative new capsule solution for intestinal (enteric) drug delivery.

The Applied Biosystems Absolute Q SARS-CoV-2 Wastewater Surveillance Kit is designed to provide rapid and consistent absolute quantitation of relevant SARS-CoV-2 targets from wastewater samples using digital PCR.

At Lab Innovations 2022, Ellutia will present the newest addition to its nitrosamine detection solutions, the Automated Total Nitrosamine Analyser (ATNA).

More companies around the world continue turning to Beckman Coulter Life Sciences for their next-generation sequencing needs with the Biomek NGeniuS System.

Arima Genomics, Inc. has announced that new data on the detection of actionable structural variants from cancer samples embedded in formalin-fixed, paraffin-embedded tissues will be presented at the Association of Molecular Pathology Annual Meeting.